1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 1, 1997
INTERPORE INTERNATIONAL
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
California 0-22958 95-3043318
- --------------------- ------------------------ -------------------
(State of (Commission File Number) (IRS Employer
Incorporation) Identification No.)
181 Technology Drive, Irvine, California 92618
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(714) 453-3200
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
- --------------------------------------------------------------------------------
(former name or former address, if changed since last report)
2
Item 2. Acquisition or Disposition of Assets.
-------------------------------------
On May 1, 1997, Interpore International (the "Company") sold certain
assets of Interpore Dental, Inc., a wholly-owned subsidiary of the Company, to
Steri-Oss, Inc., a privately-held corporation located in Yorba Linda,
California. Interpore's dental business consisted primarily of titanium dental
implants and accessories for partially and totally toothless patients. The
Company received cash in the amount of $1.5 million at the Closing and a
deferred cash payment of up to $1.5 million, subject to certain price and
indemnification adjustments, is due in January 1998. The purchase price was
arrived at as a result of arms-length negotiations between the parties. The
Company anticipates that the transaction will generate a one-time loss, which
will be recorded in the second quarter of 1997.
Pursuant to a distribution agreement entered into in connection with
the sale, Interpore has agreed to manufacture and provide its Interpore 200(R)
bone void filler for worldwide distribution by Steri-Oss in the
oral/maxillofacial market.
Item 7. Financial Statements and Exhibits.
----------------------------------
(b) Pro Forma Financial Information
It is impracticable to provide the required pro forma
information at the time of filing of this report. The required
pro forma financial information will be filed within 60 days.
(c) Exhibits
2. Asset Purchase Agreement, dated as of April 18, 1997,
between Steri-Oss, Inc. and Interpore Dental, Inc.
99. Text of Press Release, dated May 2, 1997.
2
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: May 14, 1997
INTERPORE INTERNATIONAL
By: /s/ RICHARD L. HARRISON
------------------------------
Name: Richard L. Harrison
Title: Chief Financial Officer
3
4
EXHIBIT INDEX
2. Asset Purchase Agreement, dated as of April 18, 1997, between
Steri-Oss, Inc. and Interpore Dental, Inc.
99. Text of Press Release, dated May 2, 1997.
4